EN DE
Watch RIVERSTONE HOLDINGS LIMITED for free: we tell you when fair value or trend changes.
Data-driven stock valuation

RIVERSTONE HOLDINGS LIMITED (AP4) fair value: what the stock is really worth

As of Nov 16, 2026: fair value (intrinsic value) of RIVERSTONE HOLDINGS LIMITED stock S$0.91, price S$0.73, upside +24.7%, quality 73 out of 100. Rating: undervalued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Healthcare SG · ISIN SG1U22933048

RH RIVERSTONE HOLDINGS LIMITED logo Thin data Nov 15, 2026

RIVERSTONE HOLDINGS LIMITED

AP4 · SG

Solid company, but only slightly cheap (20% below fair value) and price moving sideways: meets 1 of 3 rules.

Get notified free when this changes
Fair value 0.9100 SGD · Undervalued 
Quality 73/100 
Highly profitable · 21.7% net margin (TTM) 
Low debt 
Generates free cash flow 
17.1% dividend yield · Sustainable
Ranks above peers (15/15) 
Profit last quarter +45% vs. a year ago. 
Price moving sideways (no uptrend) 
Wide moat 76/100 · thin data
Weak Growth (revenue 5y −11.5 %/yr in SGD) 
Thin data 
Watch RIVERSTONE HOLDINGS LIMITED for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

0.9515 SGD 0.3210 SGD Fair Value 0.9100 SGD Aug 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 15, 2026.

How to read this chart

60‑month range 0.3210 SGD – 0.9515 SGD · fair‑value band 0.6400 SGD – 1.21 SGD · the 0.7300 SGD price screens below the 0.9100 SGD fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 15, 2026.

Follow RIVERSTONE HOLDINGS in your weekly email

Every Wednesday you see whether RIVERSTONE HOLDINGS is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Riverstone Holdings Limited, an investment holding company, engages in the manufacture and distribution of cleanroom and healthcare gloves in Malaysia, Thailand, and China.

Show moreShow less

The company offers cleanroom gloves, healthcare gloves, cleanroom face masks, fingercots, static shielding bags, face masks, wipers, cleanroom packaging bags, and other cleanroom consumables. It sells its products under the RS brand for use in the hard disk drive and semiconductor industries.

It also exports its products to Asia, Europe, and the United States. Riverstone Holdings Limited was founded in 1989 and is based in Singapore.

Stock analysis

RIVERSTONE HOLDINGS LIMITED (AP4) currently trades at 0.7300 SGD, while our model-based Fair Value estimate is 0.9100 SGD, implying the stock looks roughly 20% undervalued today.

Show more

Valuation

Bull case: the Multiples group reads highest at a median of 0.9900 SGD per share, and 19 of the 26 models we run sit above the 0.7300 SGD price.

Bear case: the Asset-Based group reads lowest at 0.1500 SGD, and 7 of the 26 models stay below the price. Data coverage for this calculation is low.

Scenario range: 0.6400 SGD (bear) to 1.21 SGD (bull), the price of 0.7300 SGD sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 73/100 (solid quality), in the Healthcare sector.

Weak Growth: Revenue is shrinking: the last year, the last three and the last five years are all negative.

RIVERSTONE HOLDINGS LIMITED reported revenue of 995M MYR in FY2025 versus 3.1B MYR in FY2021, a compound −24.6%/yr. Reported net income was 208M MYR in FY2025, compounding −38.1%/yr from FY2021.

Key figures

Market cap 1.1B SGD (≈ $840M) Small · P/E ratio 14.6 · P/S ratio 3.05 · EPS (TTM) 0.0500 SGD · Net margin 20.9% · Return on equity 14.7% · Return on assets (EBIT) 27.1% (5-year average) · Operating margin 27.0%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 76 out of 100 (low confidence).

What moves the price

The share trades about 23% below its 52-week high and 13% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at −44% fair-value upside, at 25%, AP4 screens cheaper than that median.

Fair Value models

Bear 0.6400 SGD Fair Value 0.9100 SGD Bull 1.21 SGD
Price 0.7300 SGD · Upside +24.7%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
FCF DCF 0.6400 SGD 0.9200 SGD 1.34 SGD 80
Growth DCF 0.6400 SGD 0.9100 SGD 1.31 SGD 78
Owner Earnings 0.6500 SGD 0.9400 SGD 1.36 SGD 76
All 26 models by family
DCF Models
FCF DCF 0.6400 SGD 0.9200 SGD 1.34 SGD 80
Owner Earnings 0.6500 SGD 0.9400 SGD 1.36 SGD 76
5Y Revenue Exit 0.5900 SGD 0.8600 SGD 1.22 SGD 73
5Y EBITDA Exit 0.7200 SGD 1.11 SGD 1.58 SGD 75
5Y P/E Exit 0.7300 SGD 1.14 SGD 1.58 SGD 71
10Y Revenue Exit 0.5900 SGD 0.8400 SGD 1.19 SGD 67
10Y EBITDA Exit 0.6800 SGD 1.01 SGD 1.46 SGD 68
10Y P/E Exit 0.6900 SGD 1.03 SGD 1.46 SGD 64
Earnings-Based
Graham-Dodd 0.3000 SGD 1.07 SGD 1.44 SGD 64
Lynch FV 0.4600 SGD 0.6600 SGD 0.8500 SGD 61
PEG = 1.0 0.4600 SGD 0.6600 SGD 0.8500 SGD 57
EPV 0.4000 SGD 0.4300 SGD 0.4700 SGD 74
Dividend Discount
Gordon GGM 0.5300 SGD 1.02 SGD 1.50 SGD 67
DDM Multi-Stage 0.5300 SGD 0.9000 SGD 1.08 SGD 67
Multiples
P/E Multiple 0.7300 SGD 0.9700 SGD 1.21 SGD 63
P/S Multiple 0.5500 SGD 0.7400 SGD 0.9200 SGD 58
P/B Multiple 1.06 SGD 1.41 SGD 1.76 SGD 55
EV/EBIT 0.7900 SGD 1.01 SGD 1.23 SGD 66
EV/EBITDA 0.8400 SGD 1.07 SGD 1.30 SGD 67
EV/Revenue 0.5800 SGD 0.7700 SGD 0.9600 SGD 54
Asset-Based
NCAV (Graham) 0.1000 SGD 0.1500 SGD 0.1900 SGD 54
Growth DCF
Growth DCF 0.6400 SGD 0.9100 SGD 1.31 SGD 78
Rev-Margin DCF 0.5900 SGD 0.8600 SGD 1.19 SGD 73
Economic Profit
Residual Income 0.3000 SGD 0.3500 SGD 0.4500 SGD 76
ROIC Compounder 0.4100 SGD 0.4900 SGD 0.5800 SGD 72
Growth Earnings
Growth-Adj P/E 0.5000 SGD 0.7100 SGD 0.9200 SGD 67

Open the full fair value analysis →

Quality Score breakdown

Overall quality 73/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 58
How much profit the company makes from its sales and capital
Quality Growth 14
Are margins and returns getting better?
Cashflow 80
Do the profits arrive as real cash?
Financial strength 100
Debt, balance sheet and risk of trouble
Investment 88
Does it invest with discipline instead of growing at any price?
Low Volatility 77
How calm the share price moves, does not count
Price momentum 26
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 26
Distance to the 52-week high, does not count
New shares 82
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 40/100
Revenue is shrinking: the last year, the last three and the last five years are all negative.
Revenue growth 1 year
−7.2%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−7.5%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−11.5%
Start year 2020 (pandemic). Over 10 years: +5.9% a year
Revenue growth 12 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+8.9%
What shareholders gained per year (last 5 years), in MYR ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in MYR: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
−20.3%
Earnings growth per share plus dividend.
Earnings per share, growth per year−20.3%
Dividend (yield on the price)0.0%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.−20.3% vs 10.2%, slowing
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.46% → 25%
Pace: the 5-year rate starts in 2020 (pandemic)

Growth Forecast

Little optimism in the price
The price assumes less growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
−33.1%
The company could shrink this much every year for the next five years and today's price would still be justified.
What forecasts expect
n/a
No analyst forecast available.
After inflation (Singapore: IMF forecast 2.0% a year to 2030, 1.7% from 2016 to 2025) that is about −34.5% a year for the price.

Watch AP4, get fair value alerts →

Compare RIVERSTONE HOLDINGS LIMITED with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Instruments & Supplies · 199 stocks

Beats the industry median on 14/14 measures
Overall it ranks above its industry peers.
Valuation
Quality Score 73 · Top 25%
Fair Value upside +24.7% · Top 25%
Profitability
Return on equity (12 months) 14.7% · Top 25%
Return on assets 12.7% · Top 25%
Net margin (12 months) 21.7% · Top 25%
Operating margin (12 months) 27.0% · Top 25%
Growth and dividend
Revenue growth (quarter YoY) 8.9% · Above median
Dividend yield (12 months) 17.1% · Top 25%

Valuation Multiplesvs Medical Instruments & Supplies median · lower = cheaper

P/E (12 months) 14.6× · Cheapest 25%
P/B 0.73× · Cheapest 25%
P/S (12 months) 1.11× · Cheapest 25%
Price / free cash flow (fiscal year) 4.9× · Cheapest 25%
EV/EBITDA 1.4× · Cheapest 25%
PEG 0.46× · Cheapest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)66 · sector 17
FUTURE (revenue growth)45 · sector 40
PAST (return on equity)59 · sector 26
HEALTH (low debt)100 · sector 96
DIVIDEND (yield)100 · sector 31

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Medical Instruments & Supplies stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Solventum Corporation SOLV $89.08 $131.27 +47% vs AP4
EssilorLuxottica Société anonyme EL €184.50 €196.22 +6% vs AP4
Intuitive Surgical, Inc ISRG $443.59 $353.90 −20% vs AP4
Medline Inc MDLN $39.47 $28.59 −28% vs AP4
Alcon Inc ALC CHF 62.14 CHF 35.08 −44% vs AP4
Becton, Dickinson and Company BDX $218.03 $97.80 −55% vs AP4
Straumann Holding STMN CHF 108.75 CHF 45.50 −58% vs AP4
West Pharmaceutical Services, Inc WST $416.42 $139.22 −67% vs AP4
Sartorius Stedim Biotech S.A DIM €225.20 €54.82 −76% vs AP4
Sartorius Aktiengesellschaft SRT €226.50 €46.44 −80% vs AP4

Explore undervalued stocks

More undervalued Healthcare stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

RIVERSTONE HOLDINGS LIMITED: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "RIVERSTONE HOLDINGS LIMITED Fair Value". https://www.fairvalue-calculator.com/stock/AP4

Frequently asked questions

Is RIVERSTONE HOLDINGS LIMITED (AP4) overvalued or undervalued?
As of Nov 15, 2026, our model estimates a fair value of 0.9100 SGD versus a price of 0.7300 SGD, about +25% upside (undervalued).
What is the fair value of AP4?
Our model-based fair value for RIVERSTONE HOLDINGS LIMITED is 0.9100 SGD (as of Nov 15, 2026), built from audited fundamentals. The current price: 0.7300 SGD.
What is the quality score of AP4?
RIVERSTONE HOLDINGS LIMITED has a Quality Score of 73/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for RIVERSTONE HOLDINGS LIMITED (AP4)?
Our model-based price target is the fair value of 0.9100 SGD (as of Nov 15, 2026) from 26 valuation models. Cautious scenario 0.6400 SGD, optimistic scenario 1.21 SGD. It is a calculation from audited fundamentals, not an analyst target.
What is the RIVERSTONE HOLDINGS LIMITED stock forecast for 2026?
Our models put fair value at 0.9100 SGD, about +25% upside versus a price of 0.7300 SGD (undervalued). Cautious scenario 0.6400 SGD, optimistic scenario 1.21 SGD. The calculation is refreshed regularly with new filings.
What is the revenue of RIVERSTONE HOLDINGS LIMITED (AP4)?
RIVERSTONE HOLDINGS LIMITED reported trailing-twelve-month revenue of about 979M SGD (latest available figure, as of Nov 15, 2026).
What growth is priced into RIVERSTONE HOLDINGS LIMITED (AP4)?
Today's price is already fair in a discounted-cash-flow model if free cash flow at RIVERSTONE HOLDINGS LIMITED shrinks by 33.1 % per year for five years (discount rate 10.0 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue fell 11.5 % per year. As of Nov 15, 2026.
What discount rate (WACC) does the fair value of AP4 use?
Our models discount RIVERSTONE HOLDINGS LIMITED at 10.0 %: a base by market capitalisation (small), damped by beta 0.62, country premium for Singapore. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For RIVERSTONE HOLDINGS LIMITED that is -33.1 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (10.0 %) and the same formula as our fair value.
How much growth has RIVERSTONE HOLDINGS LIMITED (AP4) delivered so far?
Over the past 5 years revenue at RIVERSTONE HOLDINGS LIMITED shrank 11.5 % a year. The price currently implies free-cash-flow growth of -33.1 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of RIVERSTONE HOLDINGS LIMITED (AP4) growing?
The median revenue growth in the sector is +7.3 % a year. That is the yardstick for the growth priced into RIVERSTONE HOLDINGS LIMITED (-33.1 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of RIVERSTONE HOLDINGS LIMITED (AP4)?
The free-cash-flow yield on the price is 20.57 %: that much free cash flow RIVERSTONE HOLDINGS LIMITED produces per unit of market value. When it exceeds the discount rate of our models (10.0 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of RIVERSTONE HOLDINGS LIMITED (AP4)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For RIVERSTONE HOLDINGS LIMITED it is 0.9100 SGD per share (as of Nov 15, 2026), against a price of 0.7300 SGD. It is the blended result of 26 valuation models in 8 families (DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings).
Is RIVERSTONE HOLDINGS LIMITED stock overvalued or undervalued in 2026?
As of Nov 15, 2026, AP4 trades below its calculated fair value: price 0.7300 SGD, fair value 0.9100 SGD, a gap of about +25% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of AP4?
No. The price is what the market pays today (0.7300 SGD); the fair value is what the company's own numbers justify (0.9100 SGD). For RIVERSTONE HOLDINGS LIMITED the two are 0.1800 SGD per share apart. That gap is exactly why we show both numbers side by side.
How much is RIVERSTONE HOLDINGS LIMITED worth?
The market values RIVERSTONE HOLDINGS LIMITED at about 1.1B SGD (market capitalisation, as of Nov 15, 2026). Per share that is 0.7300 SGD; our models calculate a fair value of 0.9100 SGD per share.
What do the bullish and bearish scenarios say about AP4?
Our models span a range for RIVERSTONE HOLDINGS LIMITED: cautious scenario 0.6400 SGD, base 0.9100 SGD, optimistic 1.21 SGD per share (as of Nov 15, 2026, price 0.7300 SGD). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of AP4?
RIVERSTONE HOLDINGS LIMITED trades at a price-to-earnings ratio of 14.6 (as of Nov 15, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 0.9100 SGD is built from several models across several years. Median P/E at fiscal year-end, 6 fiscal years (2020 to 2025), reported earnings: 3.8. Other multiples: PEG 0.5, P/B 0.7, P/S 1.1, EV/EBITDA 1.4.
What is the PEG ratio of AP4?
The PEG ratio of RIVERSTONE HOLDINGS LIMITED is 0.46 (P/E divided by earnings growth, as of Nov 15, 2026). That is below 1, so growth is priced more cheaply than the earnings multiple alone suggests.
How solid is the balance sheet of RIVERSTONE HOLDINGS LIMITED (AP4)?
Balance-sheet figures for RIVERSTONE HOLDINGS LIMITED (as of Nov 15, 2026): return on equity 14.7%. They feed the Quality Score of 73/100, which measures business quality independently of the share price.
How far is AP4 from its 52-week high?
RIVERSTONE HOLDINGS LIMITED trades at 0.7300 SGD, about 23% below its 52-week high of 0.9515 SGD and 13% above the low of 0.6475 SGD (as of Nov 16, 2026). Distance from the high says nothing about value: that is what the fair value of 0.9100 SGD is for.
Which stocks are comparable to RIVERSTONE HOLDINGS LIMITED?
From the same area (Healthcare) we also value Intuitive Surgical, Inc, EssilorLuxottica Société anonyme, Becton, Dickinson and Company, Medline Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is RIVERSTONE HOLDINGS LIMITED stock attractive at the current price?
The data as of Nov 15, 2026: price 0.7300 SGD, calculated fair value 0.9100 SGD (+25%), Quality Score 73/100, from 26 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of AP4 calculated?
We run RIVERSTONE HOLDINGS LIMITED through 26 models from 8 families: DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of 0.9100 SGD builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5% above its aggregate fair value. RIVERSTONE HOLDINGS LIMITED currently trades 20% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of RIVERSTONE HOLDINGS LIMITED (AP4)?
The closing price on Nov 16, 2026 was 0.7300 SGD. Our model-based fair value is 0.9100 SGD, about +25% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with RIVERSTONE HOLDINGS LIMITED right now?
Solid quality (73/100) at a price below fair value, the discount is the argument here, not the business quality. A fairly wide model range (0.6400 SGD to 1.21 SGD) leaves room in how you read the outcome. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.

Key figures of RIVERSTONE HOLDINGS LIMITED

How large is the market capitalisation of RIVERSTONE HOLDINGS LIMITED (AP4)?
The market capitalisation of RIVERSTONE HOLDINGS LIMITED is 1.1B SGD (≈ $840M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of RIVERSTONE HOLDINGS LIMITED (AP4)?
The price-to-sales ratio of RIVERSTONE HOLDINGS LIMITED is 3.05 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of RIVERSTONE HOLDINGS LIMITED (AP4)?
Earnings per share at RIVERSTONE HOLDINGS LIMITED are 0.0500 SGD (price ÷ EPS = P/E 14.6). Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of RIVERSTONE HOLDINGS LIMITED (AP4)?
The net margin of RIVERSTONE HOLDINGS LIMITED is 20.9% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of RIVERSTONE HOLDINGS LIMITED (AP4)?
The return on equity (ROE) of RIVERSTONE HOLDINGS LIMITED is 14.7% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of RIVERSTONE HOLDINGS LIMITED (AP4)?
On an EBIT basis the return on assets of RIVERSTONE HOLDINGS LIMITED is 27.1% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of RIVERSTONE HOLDINGS LIMITED (AP4)?
The operating margin of RIVERSTONE HOLDINGS LIMITED is 27.0% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at RIVERSTONE HOLDINGS LIMITED (AP4)?
Revenue at RIVERSTONE HOLDINGS LIMITED is growing 8.9% versus a year earlier (3y avg −7.5%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at RIVERSTONE HOLDINGS LIMITED (AP4)?
Earnings per share at RIVERSTONE HOLDINGS LIMITED are growing 45.0% versus a year earlier. How much earnings per share grew versus a year earlier.
Free · no account needed

Watch RIVERSTONE HOLDINGS LIMITED in the live analysis

One click puts RIVERSTONE HOLDINGS LIMITED on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.